Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas

Acta Oto-Laryngologica

Volumn 125, Issue 11, 2005, Pages 1218-1223

  Marioni, Gino ^a,b   Bedogni, Alberto ^a   Giacomelli, Luciano ^a   Ferraro, Silvia Maria ^a   Bertolin, Andy ^a   Facco, Elisa ^a   Staffieri, Alberto ^a   Marino, Filippo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE   (Italy)

Author keywords

Apoptosis inhibitor; Lymph node metastasis; Oral; Oropharyngeal; Squamous cell carcinoma; Survivin

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN; SURVIVIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ADULT; AGED; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PROGNOSIS;

EID: 29144438934     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510038194     Document Type: Article

References (21)

1. Nachmias B, Ashhab Y, Ben-Yehuda D. The inhibitor of apoptosis protein family (IAPs): an emerging therapeutic target in cancer. Semin Cancer Biol 2004;14:231-43.
2. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003;22:8581-9.
3. Chang JT, Wong F-H, Liao C-T, Chen I-H, Wang H-M, Cheng A-J. Enzyme immunoassay for serum autoantibody to survivin and its findings in head-and-neck cancer patients. Clin Chem 2004;50:1261-4.
4. International Union Against Cancer. TNM classification of malignant tumours, 5th ed. New York: Wiley-Liss; 1997.
5. Pesarin F. Multivariate permutation tests. Chichester, UK: John Wiley; 2001.
6. Dong Y, Sui L, Watanabe Y, Sugimoto K, Tokuda M. Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications. Anticancer Res 2002;22: 2377-83.
7. Pizem J, Cör A, Gale N. Survivin expression is a negative prognostic marker in laryngeal squamous cell carcinoma and is associated with p53 accumulation. Histopathology 2004; 45:180-6.
8. Lo Muzio L, Staibano S, Pannone G, Mignogna MD, Mariggio A, Salvatore G, et al. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 2001;70:249-54.
9. Tanaka C, Uzawa K, Shibahara T, Yokoe H, Noma H, Tanzawa H. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res 2003;82:607-11.
10. Lo Muzio L, Pannone G, Staibano S, Mignogna MD, Rubini C, Mariggio MA, et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer 2003;89: 2244-8.
11. Lo Muzio L, Pannone G, Leonardi R, Staibano S, Mignogna MD, De Rosa G, et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res 2003;82: 923-8.
12. Lo Muzio L, Campisi G, Giovannelli L, Ammatuna P, Greco I, Staibano S, et al. HPV DNA and survivin expression in epithelial oral carcinogenesis: a relationship? Oral Oncol 2004;40:736-41.
13. Weinman EC, Roche PC, Kasperbauer JL, Cha SS, Sargent DJ, Cheville J, et al. Characterization of antigen processing machinery and Survivin expression in tonsillar squamous cell carcinoma. Cancer 2003;97:2203-11.
14. O'Driscoll L, Linehan R, Clynes M. Survivin: role in normal cells and in pathological conditions. Curr Cancer Drug Targets 2003;3:131-52.
15. Xing Z, Conway EM, Kang C, Winoto A. Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med 2004;199: 69-80.
16. Grabowski P, Kühnel T, Mühr-Wilkenshoff, Heine B, Stein H, Hüpfner M, et al. Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 2003;88:115-9.
17. Nemoto T, Kitagawa M, Hasegawa M, Ikeda S, Akashi T, Takizawa T, et al. Expression of IAP family proteins in esophageal cancer. Exp Mol Pathol 2004;76:253-9.
18. Meng H, Lu C, Mabuchi H, Tanigawa N. Prognostic significance and different properties of survivin splicing variants in gastric cancer. Cancer Lett 2004;216:147-55.
19. Zangemeister-Wittke U, Simon HU. An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy. Cell Cycle 2004;3:1121-3.
20. Li F, Yang J, Ramnath N, Javle MM, Tan D. Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 2005;114:509-12.
21. Sharma H, Sen S, Mathur M, Bahadur S, Singh N. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 2004;26:733-40.